WEDGE CAPITAL MANAGEMENT L L P/NC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
WEDGE CAPITAL MANAGEMENT L L P/NC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,691,048
-36.2%
63,573
-40.9%
0.07%
-20.7%
Q2 2023$5,785,541
+22.5%
107,478
-9.6%
0.09%
+15.0%
Q1 2023$4,724,495
+94408.8%
118,945
-4.3%
0.08%
-1.2%
Q4 2022$4,999
-99.9%
124,270
-4.2%
0.08%
+14.1%
Q3 2022$4,170,000
+1689.7%
129,755
+2172.4%
0.07%
+1675.0%
Q1 2020$233,000
-29.6%
5,710
+6.2%
0.00%0.0%
Q4 2019$331,000
+4.1%
5,375
+23.3%
0.00%0.0%
Q3 2019$318,000
-47.6%
4,359
-41.0%
0.00%
-42.9%
Q2 2019$607,000
+26.5%
7,386
+8.6%
0.01%
+40.0%
Q1 2019$480,0006,8000.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders